Second Amendment Agreement to Share Purchase Agreement dated for reference April 19, 2010 among the Company, Natac Biotech, S.L. and the principal shareholders of Natac Biotech S.L

EX-10.5 2 exhibit10-5.htm SECOND AMENDMENT AGREEMENT TO SHARE PURCHASE AGREEMENT Caleco Pharma Corp.: Exhibit 10. 5 - Filed by newsfilecorp.com

SECOND AMENDMENT AGREEMENT TO SHARE PURCHASE AGREEMENT

THIS AGREEMENT is dated the 19th day of April, 2010.

 AMONG:  
     
NATAC BIOTECH, S.L., a Spanish corporation having an address at Calle Ana de Austria, 28660 Boadilla del Monte, Madrid, Spain
     
  (hereinafter called "Natac")  
  OF THE FIRST PART  
     
 AND:  
     
ANTONIO DELGADO ROMERO, an individual having an address at Calle Manuel de Falla 4a, 05260 Avila, Spain.
     
  (hereinafter called "Romero")  
  OF THE SECOND PART  
 AND:  
     
JOSE CARLOS QUINTELA FERNANDEZ, an individual having an address at Calle Tellez, Puerta 1, 28007, Madrid, Spain.
     
  (hereinafter called "Fernandez")  
   OF THE THIRD PART  
     
 AND:  
     
CALECO PHARMA CORP., a Nevada corporation having an address at Suite 410 – 103 East Holly Street, National Bank Building, Bellingham, WA 98225.
     
  (hereinafter called "Caleco")  
    OF THE FOURTH PART  
 WHEREAS:  

A.          Under the terms of a Share Purchase Agreement (the “Share Purchase Agreement”) dated February 10, 2010 among Natac, Caleco, Romero and Fernandez, (together, the “Vendors”), Caleco agreed to purchase from the Vendors an aggregate of 36 shares of the capital stock of Natac held by the Vendors (the “Natac Shares”). In consideration of the Natac Shares, Caleco agreed to issue an aggregate of 4,300,000 shares of its common stock to the Vendors on closing of the Share Purchase Agreement;

B.            On March 19, 2010, Natac and the Vendors entered into an amendment agreement to the Share Purchase Agreement whereby the parties agreed to extend the closing date of the acquisition of the Natac Shares from March 19, 2010 to April 19, 2010 (the “Closing Date”); and

C.              Natac and the Vendors have agreed to further extend the Closing Date to July 19, 2010 in accordance with the terms of this Agreement.

NOW, THEREFORE, in consideration of the premises contained herein and the sum of $10.00 paid by Caleco to Natac, the receipt and sufficiency are hereby acknowledged, Natac and Caleco agree as follows:

1. Definitions. Except as otherwise set out herein, capitalized terms used in this Agreement shall have the same meaning as specified in the Share Purchase Agreement.
   
2. Amendment. Section 7.1 of the Share Purchase Agreement is replaced in its entirety with the following:
   
“7.1      The closing of this Agreement shall occur on a date, time and place as mutually agreed to by the parties, but in any event no later than July 19, 2010 (the “Closing Date”).”



3.

No Other Modification. The parties confirm that the terms, covenants and conditions of the Share Purchase Agreement remain unchanged and in full force and effect, except as modified by this Agreement.

   
4.

Independent Legal Advice. This Agreement has been prepared by O’Neill Law Group PLLC acting solely on behalf of Caleco, and Natac and the Vendors acknowledge that they have been advised to obtain independent legal advice.

   
5.

Successors and Assigns. Except as otherwise expressly provided herein, the provisions hereof shall inure to the benefit of, and be binding upon, the successors, assigns, heirs, executors and administrators of the parties hereto.

   
6.

Entire Agreement. This Agreement constitutes the full and entire understanding and agreement between the parties with regard to the subject hereof.

   
7.

Counterparts. This Agreement may be executed in two or more counterparts, each of which shall constitute an original, but all of which, when taken together, shall constitute but one instrument, and shall become effective when one or more counterparts have been signed by each party hereto and delivered to the other parties.

IN WITNESS WHEREOF, the parties have duly executed and delivered this Agreement as of the date first written above.

NATAC BIOTECH S.L.

/s/ Lourdes Marquez
_______________________________
By Its Authorized Signatory

SIGNED, SEALED AND DELIVERED
BY ANTONIO DELGADO ROMERO
in the presence of:

/s/ Jose Carlos Quintela                            /s/ Antonio Delgado Romero
Signature of Witness ANTONIO DELGADO ROMERO

Jose Carlos Quintela                                   
Name

______________________________

SIGNED, SEALED AND DELIVERED
BY JOSE CARLOS QUINTELA FERNANDEZ
in the presence of:

/s/ Antonio Delgado Romero                     /s/ Jose Carlos Quintela Fernandez
Signature of Witness JOSE CARLOS QUINTELA FERNANDEZ

Antonio Delgado Romero                           
Name

_______________________________

CALECO PHARMA CORP.

/s/ John Boschert
______________________________
By Its Authorized Signatory

2